Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma

ÇELİK B., Yalcin A. D., Genc G. E., GÜMÜŞLÜ S.

JOURNAL OF BUON, vol.20, no.1, pp.280-286, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2015
  • Journal Name: JOURNAL OF BUON
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.280-286
  • Keywords: metastatic breast carcinoma, metastatic endometrial carcinoma, metastatic ovarian carcinoma, sCD200, soluble TRAIL, SERUM TUMOR-MARKERS, EPITHELIAL OVARIAN, CANCER, EXPRESSION, CELLS, APOPTOSIS, INDUCTION, STRAIL, CA-125, GENE
  • Akdeniz University Affiliated: Yes


Purpose: The purpose of this study was to evaluate the soluble Apo-2L (sApo-2L) levels in the ascitic fluid and to study its potential in detecting malignant ascites and soluble CD200 (sCD200,sOX-2) levels so as to predict its clinical usage for detecting stage 4 metastatic endometrial, ovarian and breast cancer in serum samples.